Federal agency roles in cancer drug development from preclinical research to new drug approval [[electronic resource] ] : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Autore: |
Newhouse Joseph P
|
| Titolo: |
Federal agency roles in cancer drug development from preclinical research to new drug approval [[electronic resource] ] : the National Cancer Institute and the Food and Drug Administration / / Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman
|
| Pubblicazione: | Washington, D.C., : National Academy Press, c2005 |
| Edizione: | 3rd ed. |
| Descrizione fisica: | 1 online resource (69 p.) |
| Soggetto topico: | Antineoplastic agents - Development |
| Public administration - United States | |
| Altri autori: |
MendelsohnJohn M
GelbandHellen
HerdmanRoger
|
| Note generali: | Description based upon print version of record. |
| Nota di contenuto: | ""FRONT MATTER""; ""Table of Contents""; ""1 SCIENTIFIC RATIONALE""; ""2 THE NATIONAL CANCER INSTITUTE""; ""3 THE FOOD AND DRUG ADMINISTRATION""; ""4 SUMMARY: THE ROLES OF THE NCI AND FDA IN DEVELOPING ANTICANCER AGENTS""; ""REFERENCES""; ""ACRONYMS AND ABBREVIATIONS"" |
| Titolo autorizzato: | Federal agency roles in cancer drug development from preclinical research to new drug approval |
| ISBN: | 0-309-54976-0 |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910783331003321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |